Total Payments
$46,309
2024 Payments
$38,155
Companies
31
Transactions
269
Medicare Patients
1,406
Medicare Billing
$129,652
Payment Breakdown by Category
Other$23,375 (50.5%)
Travel$9,521 (20.6%)
Consulting$6,992 (15.1%)
Food & Beverage$6,344 (13.7%)
Education$76.71 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,375 | 21 | 50.5% |
| Travel and Lodging | $9,521 | 29 | 20.6% |
| Consulting Fee | $6,992 | 3 | 15.1% |
| Food and Beverage | $6,344 | 214 | 13.7% |
| Education | $76.71 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $30,881 | 87 | $0 (2024) |
| Currax Pharmaceuticals LLC | $7,151 | 4 | $0 (2024) |
| Edwards Lifesciences Corporation | $5,103 | 12 | $0 (2023) |
| ABBVIE INC. | $550.38 | 33 | $0 (2024) |
| Novo Nordisk Inc | $491.20 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $449.91 | 21 | $0 (2022) |
| Amgen Inc. | $192.70 | 11 | $0 (2020) |
| GlaxoSmithKline, LLC. | $192.26 | 12 | $0 (2024) |
| UCB, Inc. | $120.09 | 7 | $0 (2021) |
| Janssen Biotech, Inc. | $118.94 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,155 | 97 | Lilly USA, LLC ($30,746) |
| 2023 | $5,821 | 45 | Edwards Lifesciences Corporation ($5,103) |
| 2022 | $326.19 | 12 | Novo Nordisk Inc ($189.18) |
| 2021 | $371.88 | 22 | AbbVie Inc. ($67.42) |
| 2020 | $332.17 | 20 | Amgen Inc. ($101.63) |
| 2019 | $494.23 | 27 | Astellas Pharma US Inc ($142.06) |
| 2018 | $381.53 | 22 | AbbVie, Inc. ($99.82) |
| 2017 | $426.77 | 24 | Astellas Pharma US Inc ($137.49) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Oncology | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Travel and Lodging | Cash or cash equivalent | $19.43 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Travel and Lodging | Cash or cash equivalent | $68.05 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $36.40 | General |
| Category: Obesity | ||||||
| 11/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $484.94 | General |
| 11/07/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $291.75 | General |
| 11/07/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $264.59 | General |
| 11/07/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $168.92 | General |
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $91.65 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Obesity | ||||||
| 11/01/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Consulting Fee | Cash or cash equivalent | $874.00 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $51.96 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 363 | 410 | $80,664 | $39,057 |
| 2022 | 8 | 316 | 344 | $62,738 | $30,663 |
| 2021 | 5 | 256 | 288 | $53,609 | $25,050 |
| 2020 | 9 | 471 | 513 | $78,569 | $34,882 |
Total Patients
1,406
Total Services
1,555
Medicare Billing
$129,652
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $24,308 | $12,889 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 122 | $26,718 | $9,843 | 36.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $7,991 | $6,482 | 81.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 32 | $9,440 | $4,122 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 44 | $6,600 | $2,250 | 34.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,848 | $1,507 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,274 | $778.44 | 61.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $1,225 | $748.50 | 61.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,260 | $436.60 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $23,256 | $13,150 | 56.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 112 | $23,632 | $8,907 | 37.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 18 | $5,130 | $2,442 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $4,752 | $1,879 | 39.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $1,944 | $1,590 | 81.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 19 | $1,672 | $1,296 | 77.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,176 | $701.71 | 59.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,176 | $697.29 | 59.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 88 | 88 | $19,448 | $11,585 | 59.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 131 | $26,724 | $10,100 | 37.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 41 | $5,699 | $2,322 | 40.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $986.00 | $774.56 | 78.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $752.00 | $268.26 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 116 | 116 | $24,824 | $13,324 | 53.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 122 | 158 | $31,284 | $10,804 | 34.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 25 | 25 | $3,800 | $2,942 | 77.4% |
About Dr. Tracy Norfleet, MD
Dr. Tracy Norfleet, MD is a Internal Medicine healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487680377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tracy Norfleet, MD has received a total of $46,309 in payments from pharmaceutical and medical device companies, with $38,155 received in 2024. These payments were reported across 269 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,375).
As a Medicare-enrolled provider, Norfleet has provided services to 1,406 Medicare beneficiaries, totaling 1,555 services with total Medicare billing of $129,652. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Saint Louis, MO
- Active Since 06/23/2006
- Last Updated 05/19/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487680377
Products in Payments
- ZEPBOUND (Drug) $22,999
- CONTRAVE (Drug) $7,151
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $3,415
- Humira (Biological) $237.78
- MOUNJARO (Drug) $201.78
- TALTZ (Drug) $195.21
- Myrbetriq (Drug) $157.11
- MYRBETRIQ (Drug) $144.46
- Ozempic (Drug) $134.77
- QULIPTA (Drug) $130.53
- Enbrel (Biological) $129.09
- Wegovy (Drug) $127.61
- Cimzia (Drug) $120.09
- XARELTO (Drug) $104.10
- QSYMIA (Drug) $97.14
- Cologuard Collection Kit (Device) $95.63
- Saxenda (Drug) $84.55
- VESICARE (Drug) $83.34
- Otezla (Drug) $76.85
- AREXVY (Drug) $69.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Louis
Dr. John Lasala, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Mark Fesler, Md, MD
Internal Medicine — Payments: $700,896
Internal Medicine $700,896
Dr. Katie Schroeder, Md, MD
Internal Medicine — Payments: $659,683
Internal Medicine $659,683
Edward Charbek, Md, MD
Internal Medicine — Payments: $260,967
Internal Medicine $260,967
Dr. Michael Reschak, M.d, M.D
Internal Medicine — Payments: $245,910
Internal Medicine $245,910
Dr. Osler Jay Guzon, Md, MD
Internal Medicine — Payments: $237,841
Internal Medicine $237,841